When it comes to the two different products of pharmaceutical intermediates and raw materials, many people may think that they are two different names for the same substance, but in fact, they are not. Pharmaceutical intermediate iron and raw materials are two different substances. In order to provide consumers with a deeper understanding of pharmaceutical intermediates and APIs, the following is a brief introduction to the relationship between pharmaceutical intermediates and APIs:
1. The specific substances of the two are different
As is well known, pharmaceutical intermediates, also known as organic pharmaceutical intermediates, refer to a semi-finished product that is a product in the production of certain products. And raw materials refer to the active ingredients of drugs, which are also the fundamental substances that constitute the pharmacological effects of drugs. A raw material drug is a pharmaceutical active substance formulated through methods such as chemical synthesis, plant extraction, or biotechnology.
2. The production of raw materials must rely on intermediates
A popular pharmaceutical intermediate is a chemical raw material or product used in the pharmaceutical synthesis process, as well as an intermediate product in the production of raw materials. It is a product in the synthesis of raw materials and is generated in the process steps of raw materials. It must undergo the next step of molecular change or refinement to become a substance for raw material education. And raw materials can be directly used as preparations, while intermediates can only be used to synthesize the next step of the product, through which raw materials can be manufactured.
3. Different production requirements
Pharmaceutical intermediates are intermediate products in the production of raw materials, which require a production license for the raw materials. Therefore, pharmaceutical intermediates can be produced in ordinary chemical plants. If you want to produce raw materials, you need to obtain a production license for the raw materials before production can proceed.
In summary, reliable pharmaceutical intermediates and APIs are two completely different substances. The production threshold for pharmaceutical intermediates is relatively low, while the production of APIs requires meeting higher production thresholds. To produce raw materials, it is necessary to have suitable pharmaceutical intermediates as raw materials, so it seems that the similarities and differences between the two are quite obvious.